As the U.S. government cracks down on advertising off-label uses of drugs, one company is fighting back. Allergan, which makes the drug Botox, has filed a legal action against the government, seeking the right to "share truthful, relevant information" with physicians about off-label therapeutic uses of its drugs. The action seeks a preliminary injunction to halt government enforcement that is "currently causing irreparable harm to Allergan's First Amendment rights by chilling Allergan's protected speech."
Botox Maker's Suit Injects New Life Into Off-Label Marketing Debate
October 5, 2009